← Leaderboards
Dawn Marie Wetzel
Yale University
$3,536,531
Attributed
$3,536,531
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $667.6K · FY2011–23$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,536,531 · 3
By mechanism
R01$3,039,669 · 1
K08$397,124 · 1
F32$99,738 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Michael Cappello$12,486,505
- Diane McMahon Pratt$11,622,683
- Nancy Gore Saravia$3,661,634
- Joseph M Ready$10,879,736
- Lyda Elena Osorio$727,729
Others in their field
Top investigators on “Resistance Development”
- Judith S. Currier · University Of California Los Angeles$241,935,808
- Gregory H Reaman · National Childhood Cancer Foundation$219,136,884
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$180,092,958
- Peter C Adamson · National Childhood Cancer Foundation$114,476,581
- Wafaa M. El-Sadr · Columbia University Health Sciences$113,991,858
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
Research focus
Resistance DevelopmentPharmaceutical PreparationsMouse ModelAntiparasitic AgentsPolymerizationParasitesLeadInfectionLife Cycle StagesLeishmaniasisProteinsAffectOverexpressionLesionCutaneous LeishmaniasisInhibitor/AntagonistCommunicable DiseasesCutaneousNovel TherapeuticsIn VivoIn VitroExtracellularAffinityAnthelmintics
Grant awards (12)
Targeting a New Therapy for Trypanosomatids$584,221
R01 · FY2023 · AI · contact PI
Targeting a New Therapy for Trypanosomatids$568,021
R01 · FY2022 · AI · contact PI
Targeting a New Therapy for Trypanosomatids$653,390
R01 · FY2021 · AI · contact PI
Targeting a New Therapy for Trypanosomatids$663,007
R01 · FY2020 · AI · contact PI
Targeting a New Therapy for Trypanosomatids$4,629
R01 · FY2020 · AI · contact PI
Targeting a New Therapy for Trypanosomatids$566,401
R01 · FY2019 · AI · contact PI
Targeting Entry Pathways in Leishmaniasis$131,795
K08 · FY2015 · AI · contact PI
Targeting Entry Pathways in Leishmaniasis$89,975
K08 · FY2014 · AI · contact PI
Targeting Entry Pathways in Leishmaniasis$42,400
K08 · FY2014 · AI · contact PI
Targeting Entry Pathways in Leishmaniasis$132,954
K08 · FY2013 · AI · contact PI
Cytoskeletal control of Leishmania infection$42,418
F32 · FY2012 · AI · contact PI
Cytoskeletal control of Leishmania infection$57,320
F32 · FY2011 · AI · contact PI